All In Biotech

Drug Trial Radar · NCT07194382

AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Proof of Concept (POC) Study Evaluating the Safety, Tolerability, and Efficacy of Nintedanib Solution for Inhalation (AP02) in Participants With Idiopathic Pulmonary Fibrosis (IPF) (AURA-IPF)

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Mar 10, 2026

Primary completion

Dec 2026

Study completion Jun 2027

Sponsor

Lead sponsor
Avalyn Pharma Inc.Industry
Sponsor type
Industry
First posted
Sep 26, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the impact Nintedanib Solution for Inhalation (AP02) has on lung function and key measures of fibrosis in adult patients with idiopathic pulmonary fibrosis (IPF) as well as assess its safety and tolerability. Adults 40 years of age or older with IPF who meet the inclusion and exclusion criteria can participate in this study if they are not currently on treatment for IPF, and if treated with oral nintedanib or pirfenidone, have stopped the medication for at least 3 months. Researchers will compare two different doses of AP02 to a placebo (a look-alike substance that contains no drug) to see if AP02 works to treat IPF. Participants are put into 1 of 3 groups randomly, which means by chance and will take AP02 or a placebo two times every day for 12 weeks by using a nebulizer, which is a device that provides medicine to the lungs via inhalation. Participants will visit the office 6 times and receive 1 phone call over a 16-week period. At site visits doctors regularly perform breathing tests that measure how well the lungs are working, give the patient questionnaires and will check the participants' health.

Conditions

  • Idiopathic Pulmonary Fibrosis (IPF)

Interventions

  • AP02Drug

    Oral inhalation solution

  • PlaceboDrug

    Placebo oral inhalation solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in the morning pre-dose forced vital capacity at Week 12Time frame: From enrollment to the end of treatment at 12 weeks

Locations

49 sites in 7 countries. Site status is shown where the registry gives one.

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia · Recruiting

  • Nepean Lung and Sleep

    Kingswood, New South Wales, Australia · Recruiting

  • John Hunter Hospital

    New Lambton Heights, New South Wales, Australia · Recruiting

  • Macquarie University Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Ludwig Engel Centre for Respiratory Research

    Westmead, New South Wales, Australia · Recruiting

  • Launceston Respiratory and Sleep Centre

    Launceston, Tasmania, Australia · Recruiting

  • Austin Health

    Heidelberg, Victoria, Australia · Recruiting

  • The Alfred Hospital

    Melbourne, Victoria, Australia · Recruiting

  • University of Calgary - Foothills Medical Centre

    Calgary, Alberta, Canada · Recruiting

  • Centre for Lung Health - Vancouver General Hospital

    Vancouver, British Columbia, Canada · Recruiting

  • Newfoundland and Labrador Health Services

    St. John's, Newfoundland and Labrador, Canada · Recruiting

  • Queen Elizabeth

    Halifax, Nova Scotia, Canada · Recruiting

  • Dynamic Drug Advancement

    Ajax, Ontario, Canada · Recruiting

  • University Health Network - Toronto General Hospital

    Toronto, Ontario, Canada · Recruiting

  • Centre Hospitalier de l'Université de Montréal (CHUM)

    Montreal, Quebec, Canada · Recruiting

  • Jewish General Hospital

    Montreal, Quebec, Canada · Recruiting

  • Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hôpital Fleurimont

    Sherbrooke, Quebec, Canada · Recruiting

  • CIC Mauricie

    Trois-Rivières, Quebec, Canada · Recruiting

  • Universitätsklinikum Heidelberg - Thoraxklinik Heidelberg

    Heidelberg, Germany · Recruiting

  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz

    Mainz, Germany · Recruiting

  • Pneumologisches Studienzentrum München-West

    Munich, Bavaria, Germany · Recruiting

  • Studienzentrum Dr. Keller

    Frankfurt am Main, Hesse, Germany · Recruiting

  • Greenlane Clinical Centre

    Auckland, New Zealand · Recruiting

  • Christchurch Hospital

    Christchurch, Cantebury, New Zealand · Recruiting

  • Waikato Hospital

    Hamilton, Waikato Region, New Zealand · Recruiting

  • Hospital Clínic de Barcelona

    Barcelona, Spain · Recruiting

  • Hospital HM Sanchinarro

    Madrid, Spain · Recruiting

  • Hospital Universitario de la Princesa

    Madrid, Spain · Recruiting

  • Hospital Universitario Virgen de la Victoria

    Málaga, Spain · Recruiting

  • Hospital Germans Trias i Pujol/Hospital Can Ruti

    Badalona, Barcelona, Spain · Recruiting

  • Hospital General de Granollers, Barcelona

    Granollers, Barcelona, Spain · Recruiting

  • Hospital Universitario Marqués de Valdecilla

    Santander, Cantabria, Spain · Recruiting

  • Hospital Universitario de Bellvitge

    L'Hospitalet de Llobregat, Catalonia / Barcelona, Spain · Recruiting

  • Consorci Corporació Sanitària Parc Taulí (Parc Taulí Hospital Universitari)

    Sabadell, Catalonia / Barcelona, Spain · Recruiting

  • Istanbul University Cerrahpasa Hospital

    Istanbul, Turkey (Türkiye) · Recruiting

  • Gülhane Saglik Bilimleri Fakültesi

    Keçiören, Turkey (Türkiye) · Recruiting

  • University Hospitals Birmingham NHS Foundation Trust - Heartlands Hospital

    Birmingham, United Kingdom · Recruiting

  • Royal Papworth Hospital NHS Foundation Trust

    Cambridge, United Kingdom · Recruiting

  • Aintree University Hospital

    Liverpool, United Kingdom · Recruiting

  • Royal Brompton Hospital, Guy's and St Thomas NHS Foundation Trust

    London, United Kingdom · Recruiting

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.